Autek China Inc (300595) - Total Liabilities
Based on the latest financial reports, Autek China Inc (300595) has total liabilities worth CN¥872.83 Million CNY (≈ $127.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Autek China Inc (300595) net asset momentum to track the company's year-over-year net asset growth rate.
Autek China Inc - Total Liabilities Trend (2012–2025)
This chart illustrates how Autek China Inc's total liabilities have evolved over time, based on quarterly financial data. See 300595 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Autek China Inc Competitors by Total Liabilities
The table below lists competitors of Autek China Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zillow Group Inc
NASDAQ:ZG
|
USA | $818.00 Million |
|
Jiangsu Jiangyin Rural Commercial Bank Co Ltd
SHE:002807
|
China | CN¥202.27 Billion |
|
Chinese Universe Publishing And Media Co Ltd
SHG:600373
|
China | CN¥10.15 Billion |
|
Xiamen Solex High-Tech Industries Co Ltd
SHG:603992
|
China | CN¥1.12 Billion |
|
Loma Negra Compania Industrial Argentina SA
BA:LOMA
|
Argentina | AR$865.11 Billion |
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
USA | $1.78 Billion |
|
Twenty One Capital, Inc.
NYSE:XXI
|
USA | $108.82 Million |
|
Savaria Corporation
TO:SIS
|
Canada | CA$458.12 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Autek China Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Autek China Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Autek China Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Autek China Inc (2012–2025)
The table below shows the annual total liabilities of Autek China Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥849.48 Million ≈ $124.31 Million |
-4.26% |
| 2024-12-31 | CN¥887.24 Million ≈ $129.83 Million |
+9.83% |
| 2023-12-31 | CN¥807.85 Million ≈ $118.21 Million |
+54.45% |
| 2022-12-31 | CN¥523.05 Million ≈ $76.54 Million |
+19.87% |
| 2021-12-31 | CN¥436.35 Million ≈ $63.85 Million |
+96.79% |
| 2020-12-31 | CN¥221.74 Million ≈ $32.45 Million |
+31.85% |
| 2019-12-31 | CN¥168.17 Million ≈ $24.61 Million |
+15.76% |
| 2018-12-31 | CN¥145.28 Million ≈ $21.26 Million |
+31.80% |
| 2017-12-31 | CN¥110.23 Million ≈ $16.13 Million |
+165.23% |
| 2016-12-31 | CN¥41.56 Million ≈ $6.08 Million |
-3.95% |
| 2015-12-31 | CN¥43.27 Million ≈ $6.33 Million |
+138.95% |
| 2014-12-31 | CN¥18.11 Million ≈ $2.65 Million |
+6.17% |
| 2013-12-31 | CN¥17.06 Million ≈ $2.50 Million |
+56.76% |
| 2012-12-31 | CN¥10.88 Million ≈ $1.59 Million |
-- |
About Autek China Inc
Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It a… Read more